Exelixis
EXEL
#1643
Rank
A$16.66 B
Marketcap
$58.34
Share price
-0.96%
Change (1 day)
70.54%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: A$16.66 Billion

As of January 2025 Exelixis has a market cap of A$16.66 Billion. This makes Exelixis the world's 1643th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025A$16.66 B7.32%
2024A$15.52 B41.76%
2023A$10.95 B44.02%
2022A$7.60 B-4.7%
2021A$7.97 B-1.48%
2020A$8.09 B5.9%
2019A$7.64 B-8.67%
2018A$8.37 B-27.32%
2017A$11.52 B92.1%
2016A$5.99 B239.79%
2015A$1.76 B412.03%
2014A$0.34 B-72.82%
2013A$1.26 B56.99%
2012A$0.80 B29.04%
2011A$0.62 B-29.13%
2010A$0.88 B-0.23%
2009A$0.88 B17.84%
2008A$0.75 B-27.33%
2007A$1.03 B-5.66%
2006A$1.09 B2.06%
2005A$1.07 B16.63%
2004A$0.92 B36.15%
2003A$0.67 B-19.81%
2002A$0.84 B-53.88%
2001A$1.82 B49.59%
2000A$1.22 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of Exelixis was reported to be:

A$16.82 Billion
by Nasdaq info icon info icon
A$16.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$109.91 B 559.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$205.01 B 1,130.56%๐Ÿ‡ซ๐Ÿ‡ท France
A$399.18 B 2,296.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$183.98 B 1,004.34%๐Ÿ‡บ๐Ÿ‡ธ USA
A$235.71 B 1,314.86%๐Ÿ‡บ๐Ÿ‡ธ USA
A$570.47 B 3,324.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$240.18 B 1,341.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.89 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.84 B-94.96%๐Ÿ‡บ๐Ÿ‡ธ USA